Now, research shows a person’s drink of choice may say something about their lifestyle. Simply put, beer drinkers might be lagging when it comes to diet, exercise and smoking. Lead study author ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

When Camryn Clements’ husband, an internal medicine doctor in training at the time, faced a series of health issues, the ...

The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

We spoke to a a primary care physician for tips on how to prioritize our health as we age — from our 30s through our 70s and ...

In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

In 2023, global liver disease medical societies and patient groups formalized the decision to rename non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver ...

Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...

A recent study by scientists at deCODE genetics, published in Nature Communications, offers new insights into how body mass ...

2 There are currently no treatments approved for MASLD, formerly known as nonalcoholic fatty liver disease. Instead, ...